Dennaye Fuchs
Biographic Data
| ID | 7450065 |
|---|---|
| NAME | Dennaye Fuchs |
| GIVEN NAMES | Dennaye |
| FAMILY NAME | Fuchs |
| SIGNATURE | FUCHS D |
| AFFILIATIONS | Saskatchewan Health |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 1 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
No prominent works on this page.
Reinfection following successful direct-acting antiviral therapy for hepatitis C virus infection among people with recent injecting drug use
The relatively high incidence of reinfection seen in this study underscores the importance of targeted harm reduction measures and monitoring for HCV reinfections within the first year following successful treatment among people who inject drugs. Additional research into integrated models of care incorporating harm reduction and supporting reducing risk of reinfection and HCV treatment are needed
Antiviral therapy (1 work) · Chronic hepatitis (1 work) · Drug (1 work) · Hepatitis B Virus Studies (1 work) · Hepatitis C (1 work) · Hepatitis C virus (1 work) · Hepatitis C virus research (1 work) · HIV, Drug Use, Sexual Risk (1 work) · Immunology (1 work) · Medicine (1 work)